Adocia SA ADR (ADOCY)

Currency in USD
11.80
0.00(0.00%)
Closed·
Trading near 52-week High
Fair Value
Day's Range
11.8011.80
52 wk Range
11.8011.80
Key Statistics
Prev. Close
11.8
Open
11.8
Day's Range
11.8-11.8
52 wk Range
11.8-11.8
Volume
-
Average Volume (3m)
200
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADOCY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Adocia SA ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Adocia SA ADR Company Profile

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company’s clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

Compare ADOCY to Peers and Sector

Metrics to compare
ADOCY
Peers
Sector
Relationship
P/E Ratio
UnlockNaNNaNUnlock
PEG Ratio
UnlockNaNNaNUnlock
Price/Book
UnlockNaNNaNUnlock
Price / LTM Sales
UnlockNaNNaNUnlock
Upside (Analyst Target)
UnlockNaNNaNUnlock
Fair Value Upside
UnlockNaNNaNUnlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-- / --
Revenue / Forecast
464.26K / --
EPS Revisions
Last 90 days

ADOCY Income Statement

FAQ

What Stock Exchange Does Adocia ADR Trade On?

Adocia ADR is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Adocia ADR?

The stock symbol for Adocia ADR is "ADOCY."

What Is the Adocia ADR Market Cap?

As of today, Adocia ADR market cap is 141.57M.

What Is Adocia ADR's Earnings Per Share (TTM)?

The Adocia ADR EPS (TTM) is -0.63.

When Is the Next Adocia ADR Earnings Date?

Adocia ADR will release its next earnings report on 14 Oct 2025.

From a Technical Analysis Perspective, Is ADOCY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Adocia ADR Stock Split?

Adocia ADR has split 0 times.

How Many Employees Does Adocia ADR Have?

Adocia ADR has 75 employees.

What is the current trading status of Adocia ADR (ADOCY)?

As of 03 Aug 2025, Adocia ADR (ADOCY) is trading at a price of 11.80, with a previous close of 11.80. The stock has fluctuated within a day range of 11.80 to 11.80, while its 52-week range spans from 11.80 to 11.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.